The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Olihe N. Okoro, PhD, MPH; Karen M. Bastianelli, PharmD; Ya-Feng Wen, PharmD; Elisabeth F. Bilden, MD; Brian K. Konowalchuk, MD; & Mark E. Schneiderhan, PharmD
Substance Abuse Vol. 39, Iss. 1, 2018
“To address the increase in opioid-related deaths, state legislation has been enacted with the intent to increase access of naloxone to high risk individuals. Many clinicians may not be fully aware of naloxone-related state laws that regulate prescribing and distribution of naloxone. The results of this prescriber survey suggest that providers who are more aware of state laws regarding naloxone and confident in their knowledge of dosing, administration, and writing protocols may be more willing to prescribe naloxone. The authors recommend that prescribers be educated on state-specific laws pertaining to naloxone prescribing and use.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!